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a crisis that can be resolved only 
by altering the fundamental 
principle on which it was found-
ed — provision of funding from 
general taxation, with care be-
ing free at the point of use. Al-
though the criticism was sparked 
by a February report on an in-
quiry into shortcomings at one 
hospital,1 the problems originat-
ed in 2010, when two profound 
forces were unleashed on the NHS: 
public-sector financial austerity 
and administrative reorganization. 
Together, these three factors have 
created the current turmoil.
Never before has the NHS had 
to cope with no increase in fund-
ing for a sustained period. With 
rising demand, the NHS is re-
quired to improve its productiv-
ity at an unprecedented rate of 
4% per year.2 The government is 
convinced that to achieve this 
improvement, two fundamental 
changes are needed.
The first concerns the local 
commissioning organizations that 
are responsible for purchasing 
hospital and community services 
for their geographically defined 
populations of 200,000 to 1 mil-
lion people. The 151 existing ad-
ministrative bodies called Primary 
Care Trusts, which were led by 
nonclinical managers, have been 
replaced by 212 Clinical Commis-
sioning Groups that are led by 
primary care doctors (general 
practitioners [GPs]) who, the 
government believes, will be 
more effective in controlling the 
use of the £60 billion (approxi-
mately $90 billion) spent on sec-
ondary and community care ser-
vices. (Spending on tertiary care 
— £20 billion [$30 billion] — 
will be managed at a national 
level by a new entity called NHS 
England.) The second means of 
achieving better productivity is 
by increasing the competition 
among providers of hospital and 
community services through the 
greater use of non-NHS provid-
ers (including private for-profit, 
not-for-profit, and charity or 
volunteer organizations).
Prolonged financial stringency 
and a reorganization were chal-
lenging enough without a high-
profile report suggesting that NHS 
hospitals may not be safe.1 The 
Francis Report on the inquiry into 
the Mid Staffordshire NHS Foun-
dation Trust told a sad and trou-
bling story of a hospital in which 
the humanity of care in some 
wards was appalling and in which 
the proportion of deaths deemed 
avoidable may have been higher 
than the 5% observed elsewhere in 
England and in other high-income 
countries. Despite uncertainty 
about the appropriateness of al-
lowing public inquiries to influ-
ence policy,3 the government has 
responded by announcing sever-
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al initiatives: commitment to a 
simple single rating of the qual-
ity of a hospital (despite the fact 
that an independent expert review 
panel established by the govern-
ment offered no encouragement 
for taking this approach4); a re-
view of 14 other hospitals con-
sidered “suspect” on the basis of 
their standardized mortality ra-
tios (despite the lack of validity 
of this measure5); a review of pa-
tient safety in the NHS, chaired 
by Donald Berwick; and the cre-
ation of a position for a chief 
inspector of hospitals to strength-
en the existing quality regulator, 
the Care Quality Commission 
(despite a lack of evidence that 
regulation and inspection are 
effective mechanisms for im-
provement).
For the NHS to survive in its 
present form, it will need to 
overcome four formidable chal-
lenges. The first is financial con-
straint. Although the government 
claims to be maintaining funding 
in real terms, high rates of infla-
tion in health care plus some fi-
nancial maneuvers, such as with-
holding from the NHS any funds 
in its budget that it hasn’t spent, 
mean there has been an actual 
funding reduction of almost 1% 
per year since 2011. Of greater 
concern is that social services 
have undergone a substantial cut 
of about 7% per year since 2011, 
which is resulting in more emer-
gency admissions to hospitals 
and delays in discharges. These 
problems will be exacerbated if 
the new GP-led commissioners 
succeed in shifting some care 
from hospitals to more appropri-
ate settings, since such a shift will 
further reduce the funds that 
hospitals receive. And overshad-
owing all these funding issues, 
the government’s policy of pro-
tecting the level of health care 
spending is increasingly being 
questioned in Parliament by back-
bench members of the ruling 
party (i.e., those who do not oc-
cupy positions in government) 
who are unhappy about the re-
percussions that this protection 
has for other spending areas, 
such as defense and law enforce-
ment. The final note of gloom is 
the growing realization that fi-
nancial austerity seems to be set 
to continue beyond 2015.
The second challenge is that 
the NHS may face opposition to its 
attempts to improve productivity. 
During the first 2 years of aus-
terity, improvement was achieved 
mostly by freezing (or even reduc-
ing) staff pay, a policy that will 
not be sustainable. Similarly, driv-
ing down prices paid to suppliers 
for consumables cannot be extend-
ed indefinitely. In addition, pro-
fessionals may oppose changes 
in working arrangements, such as 
requirements that hospital doc-
tors work in the evenings and on 
weekends to boost the intensity 
of use of hospital facilities. But 
it’s the more major initiatives to 
improve productivity, such as 
merging, downgrading, or clos-
ing hospitals, that will meet with 
the greatest opposition — not 
only from staff and the public, 
but also from politicians con-
cerned about being reelected. And 
in the brave new world of markets, 
opposition to structural changes 
will even come from the economic 
regulator seeking to ensure that 
competition is maintained, re-
gardless of its effect on the 
quality of care.
The third challenge is a lack 
of managerial capacity, stemming 
largely from the government’s 
imposition of a reorganization 
that had little support from key 
staff members. This problem has 
been exacerbated by widespread 
criticism of managers, in the 
wake of the Francis Report, by 
members of the public, the me-
dia, and politicians. Although 
criticisms of some clinical and 
managerial staff were justified, 
wholesale condemnation was in-
appropriate and has contributed 
to the departure of some excel-
lent managers (particularly when 
generous retirement options were 
available). The loss of managers 
is particularly apparent in the 
commissioning arena, where the 
effects will be intensified by the 
shifting of responsibility to GPs, 
most of whom will initially lack 
appropriate experience and train-
ing. Although they will receive 
technical help, it is unclear wheth-
er the initial enthusiasm of those 
GPs who have opted to take on 
this role will last. The honeymoon 
might end when GPs realize how 
uncomfortable it can be to ration 
care to patients and reduce funds 
for their local hospital.
Finally, there is concern that 
the way the NHS has been reor-
ganized will impede attempts to 
achieve greater integration of ser-
vices across health care and with 
social services — integration that 
is essential to achieving efficient, 
high-quality care.
So, will the NHS survive these 
challenges? There are three rea-
sons for optimism. First, there 
are already examples of enterpris-
ing clinicians, managers, and 
politicians working together to 
reengineer their local services in 
imaginative ways. Second, despite 
legitimate concerns about the 
quality of some services, public 
support for the NHS is undimin-
ished, as witnessed by the inclu-
sion of a celebration of the NHS 
in the Olympics opening ceremo-
ny last July and as reflected in 
national surveys. Public enthusi-
asm is mirrored not only by that 
of most clinicians and managers 
but also by the majority of poli-
ticians (including the current gov-
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ernment, even if not by all its 
backbenchers). Though partly ide-
ological, such support reflects the 
steady annual improvements in 
the NHS’s effectiveness and safety 
seen in recent years. And third, 
turmoil provides an opportunity 
for innovation. It can produce 
collective efforts in which fac-
tional interests are set aside and 
long-standing controversial issues, 
such as bringing health care and 
social services closer together 
(even by combining their budgets 
into one), are finally addressed.
Although some of the chal-
lenges in England are unique, 
the underlying problem of meet-
ing rising demand for care with 
steady or diminishing resources 
is faced by many countries. Just 
as we can learn from other health 
care systems, our experiences over 
the next few years in redesigning 
the organization and delivery of 
services will undoubtedly provide 
lessons for others.
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The National Institute for Clin-ical Excellence (NICE) was es-
tablished in 1999, primarily to 
offer professionals in Britain’s 
National Health Service (NHS) 
advice on providing care that 
meets the highest attainable stan-
dards. NICE’s role was expanded 
in 2005 to include provision of 
analogous advice to the broader 
public health community on pre-
venting ill health and maintain-
ing good health. (The name was 
changed to the National Institute 
for Health and Clinical Excellence, 
but the acronym NICE has con-
tinued to be used.)
To meet these objectives, NICE 
now has three different strands 
of responsibilities (see table),1 and 
its budget from the government 
has increased tenfold. Much atten-
tion, however, continues to focus 
on NICE’s technology appraisals 
and clinical-guideline programs.
Since 2000, the Institute has 
been publishing technology ap-
praisals — assessments of the 
clinical effectiveness and cost-
effectiveness of (mainly) new phar-
maceutical products, including 
whether providing them consti-
tutes a good use of NHS resourc-
es. Contrary to popular mythology, 
NICE rejects less than 15% of 
technologies on the grounds of 
cost-ineffectiveness. In recent 
years, manufacturers have increas-
ingly been offering the NHS, 
through NICE, “patient access 
schemes,” which can substantial-
ly reduce the price of products 
and render them more likely to 
be considered cost-effective. Such 
offers have sometimes led a prod-
uct with a negative provisional 
assessment to gain a positive final 
one, and occasionally decisions 
have been reversed because man-
ufacturers have submitted addi-
tional evidence about a product’s 
clinical effectiveness.
NICE’s clinical guidelines im-
prove the quality of care provid-
ed to NHS patients. For example, 
after the publication of a guide-
line on the prophylactic use of 
antibiotics in patients with me-
chanical cardiac lesions, the vol-
ume of prescriptions by dental 
surgeons fell by more than 80% 
in 6 months.2 Similarly, as a re-
sult of a guideline on preventing 
venous thromboembolism, the rate 
of risk assessments in patients 
admitted to NHS hospitals in-
creased from less than 40% in 
2010 to 94% in 2012.3 Not all 
NICE’s clinical guidelines have 
had such an effect: the Institute’s 
guidance on managing infertili-
ty, including the use of in vitro 
fertilization, was fully adopted by 
only about 25% of primary care 
trusts (the regional administrative 
bodies that, until recently, com-
missioned and provided health 
care services to NHS patients).
NICE distinguishes clinical 
guidelines defining optimal care 
pathways for specific conditions 
from standards describing generic 
competencies for health care pro-
fessionals. Professional standards 
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